ISRCTN72526711已完成不适用
A randomized, open-labelled, parallel, comparative study of the efficacy and tolerability of rosuvastatin in low-density lipoprotein-cholestrol reduction using different dosing regimens of 5 mg daily, 10 mg daily and 10 mg on alternate days in Hong Kong Chinese type 2 diabetic patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Type 2 diabetic patients 18 to 75 years of age
- •2. Treated with diet alone, oral hypoglycemic agents and/or insulin
- •3. LDL-Cholesterol >/= 2.6 mmol/l
- •4. Dyslipidaemia persisting after diet control for eight weeks or more
- •5. Alcohol consumption <50 g/day
- •6. Not on treatment with drugs known to interfere with glucose tolerance or drugs that have a major effect on lipid metabolism e.g. thiazide diuretics and beta-blockers
- •7. Good compliance to diet and drugs
- •8. HbA1c <9% (glucosylated haemoglobin <9%)
- •9. Blood pressure <160/95 mmHg
排除标准
- •1. Significantly impaired renal function (plasma creatinine >150 micromol
- •2. Impaired liver function (Serum Glutamic Pyruvic Transaminase [SGPT] or alanine aminotransferase [ALT] twice the upper limit of normal)
- •3. Secondary dyslipidaemia, diabetic dyslipidaemia
- •4. Pregnant women or those planning a pregnancy
- •5. Lactation
- •6. Progressive fatal disease
- •7. History of drug or alcohol abuse
- •8. History of hypersensitivity to study medication or drugs with a similar chemical structure
- •9. Likelihood of requiring treatment during the study period with the following drugs: cyclosporine, erythromycin
研究者
相似试验
已完成
3 期
Clinical trial to evaluate the efficacy and safety of the fixed dose combination of Tramadol 50 mg IR + Diclofenac 75 mg SR vs fixed dose combination of Tramadol 37.5 mg + Paracetamol 325 mg in treatment of patients with moderate to severe pain due to acute musculoskeletal conditions , acute flare of osteoarthritis , acute flare of rheumatoid arthritis and post operative paiCTRI/2011/091/000150Abbott Healthcare Private Limited, Mumbai200
已完成
4 期
Study to examine the body response of Peg-filgrastim against Neulasta® along with Chemical agent in Patients with Breast Cancer who will be selected in any order to a known treatment.CTRI/2018/02/011914upin Limited Biotechnology Division138
尚未招募
3 期
A clinical trial to study the efficacy and safety of Budesonide Dry Powder Inhaler Rotacaps in Patients with Mild to Moderate Asthma.CTRI/2011/06/001788Inventia Healthcare Private Limited20
尚未招募
不适用
Ayurvedic Management of Bronchial Asthma-A Clinical StudyCTRI/2020/09/027878Dr Abhijith
进行中（未招募）
1 期
A Comparative, Open-Label, Controlled, monocentric study to determine the serum and Intraperitoneal fluids concentrations of vaginal applications of danazol (100mg/die) in comparison to administration of danazol oral capsules (600mg/die) in groups of women with suspected or confirmed endometriosis and scheduled for laparoscopy.MedDRA version: 20.0Level: LLTClassification code 10014789Term: Endometriosis, site unspecifiedSystem Organ Class: 100000004872endometriosisEUCTR2017-000988-32-ITVIRAMAL LIMITED24